Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 8:12:2687-2693.
doi: 10.2147/COPD.S145253. eCollection 2017.

Acute exacerbations of COPD: risk factors for failure and relapse

Marco Mantero  1   2 , Paola Rogliani  3 , Marta Di Pasquale  1   2 , Eva Polverino  4 , Ernesto Crisafulli  5 , Monica Guerrero  6 , Andrea Gramegna  1   2 , Mario Cazzola  3 , Francesco Blasi  1   2
Affiliations
Review

Acute exacerbations of COPD: risk factors for failure and relapse

Marco Mantero et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Acute exacerbations are a leading cause of worsening COPD in terms of lung function decline, quality of life, and survival. They also have a relevant economic burden on the health care system. Determining the risk factors for acute exacerbation and early relapse could be a crucial element for a better management of COPD patients. This review analyzes the current knowledge and underlines the main risk factors for recurrent acute exacerbations. Comprehensive evaluation of COPD patients during stable phase and exacerbation could contribute to prevent treatment failure and relapses.

Keywords: COPD; exacerbations; infections; prevention; treatment.

PubMed Disclaimer

Conflict of interest statement

Disclosure MM reports travel grant and congress participation from Boehringer Ingelheim, Menarini, Vivisol and Astra Zeneca and personal fees from Guidotti-Malesci and Grifols. PR has participated as a lecturer, speaker and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Menarini Group, Mundipharma and Novartis. The Department of Systems Medicine of the University of Rome “Tor Vergata” was funded by Almirall, Boehringer Ingelheim, Novartis and Zambon to conduct research in the respiratory field. EP reports fees and consultancies from Bayer, consultancies for Insmed, Grigols and Polyphor and fees from Menarini, Zambon and Pfizer. AG reports research grant from Boehringer, travel grant and congress participation from Menarini and advisory board participation from Vertex. MC has participated as a lecturer, speaker and advisor in scientific meetings and courses under the sponsorship of Almirall, AstraZeneca, Biofutura, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmith Kline, Menarini Group, Lallemand, Mundipharma, Novartis, Pfizer, Verona Pharma and Zambon and is or has been a consultant to Chiesi Farmaceutici, Lallemand, Novartis, Verona Pharma and Zambon. FB reports personal fees from AstraZeneca, Bayer, Chiesi, Dompé, GSK, Guidotti, Grifols, Menarini, Novartis, Pfizer and Zambon and grants from Bayer, Chiesi, Guidotti, Menarini, Pfizer, Teva and Zambon. MDP, EC and MG report no conflicts of interest in this work.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Doll H, Miravitlles M. Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics. 2005;23(4):345–363. - PubMed
    1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. - PMC - PubMed
    1. Anzueto A, Leimer I, Kesten S. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–251. - PMC - PubMed
    1. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161(5):1608–1613. - PubMed
    1. Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, et al. Clinical audit of COPD patients requiring hospital admission in Spain: AUDIPOC study. PLoS One. 2012;7(7):e42156. - PMC - PubMed

MeSH terms